UPDATE 1-US group wants Botox warning after 16 death reports

FDA spokeswoman Karen Riley said the agency would not comment while the Public Citizen petition was under review.

Allergan shares closed down 1.4 percent to $64.12 at the end of regular trading Thursday on the New York Stock Exchange. (Editing by Tim Dobbyn)